Collateral about our tissue analysis services, processes, technology, and regulatory support for pharma and clinical diagnostics. eGuidebook: Accelerating Drug Development Through Innovative Tissue AnalysisExplore our guide for key scientists and managers in immuno-oncology drug development Our Process at Flagship BiosciencesOur flyer shares how, by combining patented technology with a unique, proprietary process, Flagship delivers better data with more actionable insights Driving Your Biomarker Strategy: Facts by the NumbersThis info. sheet explains how Flagship provides rich, contextual biomarker data services, powered by proprietary image analysis technology, that empowers our pharmaceutical partners to make confident clinical decisions Phase 1 Through Companion Diagnostics (CDx) SupportDiscover how drug development success improves with co-development of an appropriate companion diagnostic biomarker in this detailed info. sheet Global Regulatory Strategy And Regulatory Submission SupportLearn about Flagship’s regulatory support for your development team through every phase of your drug development life cycle in this info. sheet Tissue Image Analysis and Biomarker Assessment Implementation Benefits This white paper shows how you can improve your return on investment, accelerate trials, and minimize budget impacts